Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 06:56:40 UTC
Update Date2021-09-26 23:01:09 UTC
HMDB IDHMDB0249978
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide
DescriptionN-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidic acid belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. Based on a literature review very few articles have been published on N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(3r)-1-(2-fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1h-indole-2-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-[9-(2-Fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0,]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidateGenerator
Chemical FormulaC26H19FN4O2
Average Molecular Weight438.462
Monoisotopic Molecular Weight438.149204031
IUPAC NameN-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4,6,8(13),9-tetraen-11-yl]-1H-indole-2-carboxamide
Traditional NameN-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4,6,8(13),9-tetraen-11-yl]-1H-indole-2-carboxamide
CAS Registry NumberNot Available
SMILES
FC1=CC=CC=C1C1=NC(NC(=O)C2=CC3=CC=CC=C3N2)C(=O)N2CCC3=CC=CC1=C23
InChI Identifier
InChI=1S/C26H19FN4O2/c27-19-10-3-2-8-17(19)22-18-9-5-7-15-12-13-31(23(15)18)26(33)24(29-22)30-25(32)21-14-16-6-1-4-11-20(16)28-21/h1-11,14,24,28H,12-13H2,(H,30,32)
InChI KeyWKJDXKWFGJWGAS-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentN-acyl-alpha amino acids and derivatives
Alternative Parents
Substituents
  • N-acyl-alpha amino acid or derivatives
  • Indolecarboxylic acid derivative
  • Indolecarboxamide derivative
  • Benzodiazepine
  • 1,4-benzodiazepine
  • Indole
  • Indole or derivatives
  • 2-heteroaryl carboxamide
  • Pyrrole-2-carboxamide
  • Pyrrole-2-carboxylic acid or derivatives
  • Halobenzene
  • Fluorobenzene
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Benzenoid
  • Substituted pyrrole
  • Heteroaromatic compound
  • Pyrrole
  • Tertiary carboxylic acid amide
  • Carboxamide group
  • Ketimine
  • Secondary carboxylic acid amide
  • Lactam
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Organoheterocyclic compound
  • Azacycle
  • Organic nitrogen compound
  • Organohalogen compound
  • Imine
  • Organofluoride
  • Organonitrogen compound
  • Organooxygen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.45ALOGPS
logP3.95ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)14.15ChemAxon
pKa (Strongest Basic)-0.061ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area77.56 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity122.47 m³·mol⁻¹ChemAxon
Polarizability45.71 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-232.44130932474
DeepCCS[M+Na]+207.57430932474
AllCCS[M+H]+205.932859911
AllCCS[M+H-H2O]+203.432859911
AllCCS[M+NH4]+208.132859911
AllCCS[M+Na]+208.732859911
AllCCS[M-H]-201.332859911
AllCCS[M+Na-2H]-200.632859911
AllCCS[M+HCOO]-200.032859911

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O3853.0Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O3629.9Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O5433.5Standard polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C213958.3Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C213692.0Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C215412.7Standard polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O3874.2Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O3693.5Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O5026.0Standard polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O4051.1Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O3860.0Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O5412.2Standard polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C214102.1Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C213905.1Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C215394.5Standard polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O4161.7Semi standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O4122.7Standard non polar33892256
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O5016.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, Positivesplash10-006x-6733900000-ae89497d4704e6db71d22021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 10V, Positive-QTOFsplash10-000i-0210900000-93f9b90b9a72c84ea2632021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 20V, Positive-QTOFsplash10-000i-0121900000-e26a888880919fb6293d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 40V, Positive-QTOFsplash10-0006-2890200000-5675e18fe54808b5d0622021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 10V, Negative-QTOFsplash10-014i-0100900000-2b1410cdbc7c57cbe9c02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 20V, Negative-QTOFsplash10-014i-0402900000-2b4e0c300b020242b0262021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 40V, Negative-QTOFsplash10-016r-1591200000-4661948d0b13725551662021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID14208438
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound14748561
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]